Piper Sandler Reiterates Neutral on KORU Medical Systems, Lowers Price Target to $4.5

Benzinga · 2d ago
Piper Sandler analyst Jason Bednar reiterates KORU Medical Systems (NASDAQ:KRMD) with a Neutral and lowers the price target from $5 to $4.5.